Events

As the allogeneic cell therapy space continues to mature with over 150+ clinical trials currently underway, and landmark milestones achieved with the first FDA approvals for allogeneic cell products - all eyes are turning to the backbones of these cell therapies - the cell donors. The field is awakening to the challenging reality of the increased demand for donor material to meet the required dosing needs for later stage clinical trials and licensed products. Enter the timely arrival of the inaugural Donor Selection and Cell Source Summit, the pioneering forum for cell therapy leaders within process development, supply chain, procurement, R and D and analytics, placing a spotlight focus on cell source starting material for the first time. With experts showcasing in-depth case studies of no…

Heightened attention from regulators on product and process quality is causing movement away from traditional mAb platforms to tailored, modified processes for complex biologics, creating a huge unmet need for a platform for experts dedicated to purification alone. The Advanced Purification for Complex Biologics Summit is the only standalone conference focused on purification for biologics and novel modalities bringing together purification, CMC and MSAT professionals to collaborate and remove purification bottlenecks to meet market delivery timelines. This in-depth 3-day event will feature the latest breakthroughs and cutting-edge content in AI and digital learning tools to help you save time during downstream processing and boost efficiency. This is your unique opportunity to meet 60+ pu…

Online, Online, Online, Online, Online, Online,

Achieve confidence that your company is GCP inspection ready by walking through every step of the inspection preparation and execution process. Leave having heard directly rom the regulators themselves about inspection trends, what you need to implement to ensure you are prepared, and understand how technology and effective training can be utilized to drive a culture of quality, and a continued state of GCP inspection readiness. TOP REASONS TO ATTEND- Discuss quality culture as the heart of any successful inspection readiness plan- Assess current inspection risks to provide the building blocks for your GCP inspection readiness plan- Utilize mock inspections as a quality tool to focus risk mitigation efforts- Understand the current regulatory environment and the impact on GCP inspections- H…

From personalized therapies to precise drug delivery systems, synthetic biology offers the chance to revolutionize diagnostics, treatment, and even disease prevention, ushering in a new era of medical possibilities that hold the potential to reshape human health and well-being. Join us in harnessing the potential of this nascent, modality-agnostic field brimming with cutting-edge technology, from case studies on optimized drug delivery mechanisms to proteomics and analytical strategies, we're offering a panoramic view of the future. The Synthetic Biology-Based Therapeutics Summit is your only opportunity to keep up with the latest research, bridge the gap between academia and industry and help support your internal discovery and translational development strategy – we hope to see your team…

Stroke Congress 2023 is an annual meeting of neurological and stroke specialists and other allied professionals to deliberate the innovations with respect to treatment , diagnosis and rehabilitation for neurological disorders.Stroke Congress 2023  will feature the latest and arising topics in stroke care, for stroke professionals, neurologists, researchers, and policy makers.

Announcing SynbiTECH 2023   We are excited to introduce SynbiTECH 2023, the must-attend event of the year for professionals in the fields of synthetic biology (engineering biology), biotech, business, engineering, and technology.   Date: 5th – 6th December Location: IET London: Savoy Place WC2R 0BL  Theme: Building a multibillion-dollar synthetic biology industry with positive impact      Why Attend SynbiTECH 2023?  1.     World-Class Speakers - This year our keynote speakers are: Sir Brian Hoskins - Founding Director of the Grantham Institute for Climate Change and the Environment and Mary E. Maxon, PhD - Executive Director of Schmidt BioFutures [US] (an effort focused on maximisin…

As neuroscience R and D surges with investment to solve the field's most pressing challenge, access to the brain, the 5th CNS Drug Development Summit will provide an unmissable showcase of the latest innovations to revolutionize therapeutic administration routes to the brain and optimize dose specificity. Join neuroscientists, neurobiologists, neuro-oncologists, protein engineers, biochemists, and CNS device experts from the likes of Roche, AbbVie, Takeda, Lundbeck, Sanofi, Biogen, Alnylam Pharmaceuticals and Bristol Myers Squibb this December as they reunite to translate their novel brain delivery technologies into the clinic.  URLs:Tickets: https://go.evvnt.com/1879346-2?pid=185Brochure: https://go.evvnt.com/1879346-3?pid=185 Prices:Drug Developer Pricing - Conference + Wo…

Bringing together technical case studies with actionable insights, the 2nd TPD Assay Development & Screening Summit returns as the first and only industry-dedicated conference to support in-house assay development and screening strategies to find new targets, uncover novel ligands, unravel the MOA, progress beyond CRBN and VHL, improve high throughput methods and progress from early discovery to drug candidate with scalable compounds.With promise shown using technologies like DELs, CryoEM and HDX-MS, join us as we take a deep dive into the persisting challenges holding back the progression of candidates into pre-clinical studies by exploring the best methodologies at your disposal across AI/ML guided structure-based drug design, proteomics-led, or cell-based assay approaches.

With drug developers and manufacturers facing closer scrutiny on product quality than ever before, it's time to make the most of evolving process analytical technology to design robust and cost-effective control strategies and understand more about your biopharmaceutical products. The likes of Bristol Myers Squibb, BMS, Vertex, Moderna, Sanofi and Novo Nordisk and more are uniting this December at the 2nd PAT and Real Time Quality Summit to revolutionize real-time quality strategies across a wide range of novel modality applications, and share advances in machine learning that are making real-time control and diversion a reality. Whilst the sector still battles with justifying investment and integration, the summit demonstrates tangible return on investment for process analytical technolog…

With the number of new clinical ADC targets reaching an all-time high, the 3rd ADC Target Selection Summit returns as the only industry-specific meeting spotlighting the latest developments in the field that will continue progressing first- and best-in-class ADCs through the clinic. Providing a greater focus on identifying and validating novel targets, re-examining what makes a good target, and analyzing how novel linker-payload technologies are changing the target selection paradigm; this is your unique opportunity to delve into the use of proteomics to ensure you get the first step of drug development right. With 100+ ADC enthusiasts set to be in the room including Iksuda Therapeutics, Merck and Co, Angiex, Ziel Bio, and Seagen; this is your chance to connect with peers working exclusive…

Your Dedicated Forum for Opening the Doors to New Enzyme-Enabled Chemistries for Process Ready and Scalable Synthesis In 2023, an era of advanced protein engineering technology is rapidly creating new opportunities for the generation of game-changing enzymes for novel transformations. With renewed excitement in their application for faster, cheaper and sustainable means of small molecule and API production without the need for precious metal catalysts, biocatalysis is fast being prioritized as biopharma's synthesis route of choice. Join industry titans in Biocatalysis, Enzyme Engineering, MedChem and Process Chemistry uniting at the 3rd Applied Biocatalysis Summit this December, to accelerate enzyme discovery and engineering, discover carbon footprint-reducing reactions and refine their pr…

Despite the exciting advancements and investments accelerating the development of mRNA therapies, there is still limited regulatory guidance. Moreover, developing standardized and sensitive assays to assess quality and stability still remains a key challenge. The mRNA Assay Development Summit is the first and only meeting to address the specific technical challenges of analytical, bioanalytical and potency assay development, it will allow the field to develop a set of best practices to accelerate the movement of mRNA drugs through the clinic and to the patients. This meeting will showcase critical expertise and the latest assays developed by key industry players. Join 60+ industry experts, including Moderna, Sanofi, Beam Therapeutics and more this December! Address key bottlenecks in the f…

Nanoscience 2023 UPDATE!! Meet you all in Madrid, Spain on December 07-09, 2023. We ecstatically welcome you all to the “27th International Conference on Advanced Nanoscience and Nanotechnology”. This conference is meticulously scheduled during December 07-09, 2023 in Madrid, Spain. Conference URL: https://nanoscience.alliedacademies.com With an exciting theme, “Investigate the future prospects in Nanoscience and Nanotechnology”, this year we can provide you with a world-class scientific program spanning all areas of Nanotechnology and their intersections with other fields of critical importance to our future including Nanomedicine, Health, and other sectors. Nanoscience 2023 is a great platform to bring together leading academic researchers, professionals, delegates, entrepreneurs, and in…

The 2nd LNP Immunogenicity and Toxicity Summit is set to unite 100+ PKPD, Immunology, Safety, Toxicology experts from biopharma and academia. This is your opportunity to join key opinion leaders within the industry to explore the steep progress being made in the space and actively address the field's most pressing challenges through multiple deep-dive discussions. In collaboration with Pfizer, BioNTech, Sanofi and Eli Lilly, this 3-day summit will bring together senior leaders dedicated to understanding and predicting the next wave of LNP's immunogenicity and toxicity challenges, to support drug developers to ensure smooth filing with long-term patient safety in mind. This year we are moving alongside the pharmaceutical industry and bringing the focus to accurately measuring immuno-tox of…

The field of targeted covalent therapeutics is seeing a surge of activity, with both new and established companies investing heavily in the space. The inaugural Covalent Drug Discovery Summit has been built alongside industry experts to provide a dedicated forum to tackle associated challenges and advance covalent therapeutics; previously only afforded a small feature in larger 'small molecule' conferences. As the very first meeting solely focused on covalent therapeutics, the 18+ speaker faculty boasts leaders from large pharma, new biotech and academia. This is the summit to meet 80+ covalency experts gathering to solve target selectivity, hit screening, lead optimization, and covalent warhead design to carve out covalency's niche for targeting the "undruggable" proteome.

Join us at the Digital Health Partnering Summit, Where we bring Together Industry-leading Dealmakers, Innovators, Investors & Decision-makers from the Pharma Biotech Sector. This Exclusive Event is Dedicated to Exploring the Latest Advancements in Digital Health Therapies &Technologies. Creating a Dynamic Platform for Collaboration, Business Opportunities, & Fostering Innovation. Expand your Knowledge and Gain valuable Insights into the Rapidly Evolving Digital Health Landscape. Our Agenda Features Engaging Keynote Presentations, Thought-provoking Panel Discussions, Interactive Breakout Sessions, and Dedicated Networking Opportunities. You'll stay at the Forefront of the Latest Trends and Innovations, and Delve into Discussions Surrounding the Challenges and Opportunities that…

2023 has seen advances in artificial intelligence, screening tools and progression into the clinic coupled with numerous strategic collaborations and investments into early discovery has re-fuelled the need to discover selective small molecules to drive drug development forward. In this context, the RNA Targeted Drug Discovery and Development Summit returns for its 6th year as the most comprehensive, end-to-end meeting, uniting 200+ RNA targeting experts to explore how the latest technologies are improving target validation to fast-track lead optimization and overcoming species difference challenges so more safe and effective drugs can advance into the clinic.   Time: 8:15 AM - 4:15 PM

Welcome to the 8th Oncolytic Virotherapy Summit: Engineering Oncolytic Viruses Towards Revolutionary Anti-Cancer Immunotherapies Recent years have seen highly promising and rapid advances in the pre-clinical development and clinical evolution of oncolytic virotherapies. They are increasingly being recognised as a therapy with huge potential to change the landscape for cancer immunotherapy. In the past 3 months alone, we have witnessed 20 new drugs entering into pre-clinical and clinical phases, and exciting FDA Fast Track Designation for Candel Therapeutics OV candidate - this community continues to maximize the impact of these hopeful therapies. Unite with 100+ OV trailblazers across sessions spanning Early Discovery, Translation, Clinical Development, Chemistry, Manufacturing and Control…

Gene therapy developers are striving to platform their process development to more quickly and cost-effectively bring their drugs to market, meaning optimizing upstream process development has never been a greater priority for this community. The first Gene Therapy Process Development is your only specific gene therapy event with optimizing process development with the transgene at the forefront of mind. Join your biopharma colleagues from the likes of Ultragenyx, Janssen, REGENXBIO and more, for two days of cutting-edge talks on cell-line development, scale-up, transfection, purification, analytics, and regulation. This must-attend meeting is your chance to share ideas, successes, and challenges, and capitalize on the latest advances in process development to bring safe and effective drug…

Following proof of concept in oncology, misfolded and aggregated pathological proteins across CNS indications are the new frontier for protein degradation technologies. Heading to Boston, the Targeted Protein Degradation for CNS Summit is uniting 50+ experts with 3-days of industry-focused content solely dedicated to delivering and translating TPD technologies to degrade undruggable extracellular and intracellular CNS proteins. Don't miss your chance to join industry leaders pioneering the exploration of PROTACs, AUTOTACs, molecular glues, and more revolutionary TPD technologies against CNS targets. This is your only chance to attend an industry-focused meeting dedicated to showcasing early CNS biopharma investment and overcoming your challenges to translate safe and efficacious protein de…